NCT03284138View on ClinicalTrials.gov

Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of First Rank Symptoms (FRS) on Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 3, 2018

Primary Completion Date

March 2, 2023

Study Completion Date

March 3, 2023

Conditions
Schizophrenia Patients With First Rank Symptoms
Interventions
DEVICE

rTMS treatment

patient will be treated with 10 sessions in 5 days with low frequency (1Hz) of Repetitive Transcranial Magnetic Stimulation (rTMS)

DEVICE

placebo treatment

patient will be treated with 10 sessions in 5 days with low frequency (1Hz) of Sham-controlled

Trial Locations (1)

92700

Louis Mourier, Colombes

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03284138 - Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of First Rank Symptoms (FRS) on Schizophrenia | Biotech Hunter | Biotech Hunter